← Merck KGaA
Episodes featuring Merck KGaA
53 episodes, newest first.
- Oct 1, 2026
AI deals lift Accenture and Synopsys as Moderna faces valuation testStock MoversOct 1, 2026 - Oct 1, 2026
Cockpit attack and Trump-Fed clash drive morning headlinesBloomberg Daybreak: US EditionOct 1, 2026 - Sep 30, 2026Moderna’s rally collides with valuation risk as Robinhood expands marketsStock MoversSep 30, 2026
- Sep 28, 2026
Scott Galloway weighs risk, mobility, and leverageOffice Hours with Prop GSep 28, 2026 - Sep 25, 2026AI momentum lifts Meta as Gen Digital stumblesStock MoversSep 25, 2026
- Sep 25, 2026
Three stocks expose AI fervor, deal risk and biotech promiseStock MoversSep 25, 2026 - Sep 22, 2026Shopify, Moderna and On ride distinct catalystsStock MoversSep 22, 2026
- Sep 18, 2026
Enterprise AI stalls without organizational contextThe a16z ShowSep 18, 2026 - Sep 17, 2026
Tarlov makes the case for disagreement without alienationRaging Moderates with Scott Galloway and Jessica TarlovSep 17, 2026 - Sep 14, 2026
AI leaders weigh safety against the cost of staying aheadMotley Fool Hidden Gems InvestingSep 14, 2026 - Sep 14, 2026
Jensen Huang argues AI progress needs guardrails, not a haltAll-In with Chamath, Jason, Sacks & FriedbergSep 14, 2026 - Sep 13, 2026
Biotech’s rally tests the promise of cancer breakthroughsWSJ's Take On the WeekSep 13, 2026 - Sep 8, 2026
China turns biotech strength into strategic leverageOffice Hours with Prop GSep 8, 2026 - Sep 3, 2026
Personalized vaccines target melanoma’s returnScience FridaySep 3, 2026 - Sep 2, 2026Moderna turns tumor mutations into personalized cancer vaccinesThe a16z ShowSep 2, 2026
- Aug 30, 2026
Cancer vaccine faces a political test in AmericaGlobal News PodcastAug 30, 2026 - Aug 29, 2026
AI’s next bottleneck may be memory, not computeMoonshots with Peter DiamandisAug 29, 2026 - Aug 28, 2026Markets punish uncertainty as cities race toward smarter growthStock MoversAug 28, 2026
- Aug 28, 2026PayPal deal collapse rattles fintech as Affirm gainsStock MoversAug 28, 2026
- Aug 28, 2026
Moderna bets cancer vaccine can outlast its COVID boomThe Journal.Aug 28, 2026 - Aug 26, 2026
Meta settlement puts teen-platform safeguards under scrutinyWSJ What’s NewsAug 26, 2026 - Aug 25, 2026AI pressure reshapes software and cybersecurity stocksStock MoversAug 25, 2026
- Aug 23, 2026
Moderna’s melanoma vaccine tests biotech optimismEquity Mates Investing PodcastAug 23, 2026 - Aug 22, 2026Markets absorb a volatile week of falling stocks and rising oilWSJ What’s NewsAug 22, 2026